Literature DB >> 9272499

MRI screening for acoustic neuroma without gadolinium: value of 3DFT-CISS sequence.

R Hermans1, A Van der Goten, B De Foer, A L Baert.   

Abstract

To evaluate the efficacy of a gradient-echo sequence (3DFT-CISS) in the diagnosis of acoustic neuromas, two independent observers twice reviewed the images of the temporal bones of 83 patients. Contrast-enhanced T1-weighted spin echo images were used as the reference, showing 18 acoustic neuromas, including 5 purely intracanalicular and one intralabyrinthine tumours. High sensitivity (89-94%), specificity (94-97%) and accuracy (94-95%) were found. Intraobserver (kappa 0.93-1) and interobserver (kappa 0.83-0.84) reproducibility were very good. The smallest intracanalicular tumour was overlooked twice by both observers; the intralabyrinthine tumour once by one observer. All tumours were detected with a less stringent decision criterion, at the expense of lower specificity.

Entities:  

Mesh:

Year:  1997        PMID: 9272499     DOI: 10.1007/s002340050474

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  11 in total

1.  Balanced Steady-State Free Precession Techniques Improve Detection of Residual Germ Cell Tumor for Treatment Planning.

Authors:  W A Mehan; K Buch; M F Brasz; F F J Simonis; S MacDonald; S Rincon; J E Kirsch; P Caruso
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-30       Impact factor: 3.825

2.  Screening for cerebellopontine angle tumors: is a CISS sufficient?

Authors:  Einar Goebell; Thorsten Ries; Thomas Kucinski; Ullrich Grzyska; Bernd Eckert; Jens Fiehler; Britta Eickhoff; Jan Regelsberger; Christoph Koch; Herrmann Zeumer
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

3.  Should we be moving to a national standardized non-gadolinium MR imaging protocol for the surveillance of vestibular schwannomas?

Authors:  Stuart Currie; David Saunders; Jeremy Macmullen-Price; Sanjay Verma; Philip Ayres; Caroline Tait; Ceryl Harwood; Andrew Scarsbrook; Ian J Craven
Journal:  Br J Radiol       Date:  2019-01-23       Impact factor: 3.039

4.  Diagnostic accuracy of screening MR imaging using unenhanced axial CISS and coronal T2WI for detection of small internal auditory canal lesions.

Authors:  T A Abele; D A Besachio; E P Quigley; R K Gurgel; C Shelton; H R Harnsberger; R H Wiggins
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-17       Impact factor: 3.825

5.  Cost-effectiveness analysis of a non-contrast screening MRI protocol for vestibular schwannoma in patients with asymmetric sensorineural hearing loss.

Authors:  Matthew G Crowson; Daniel J Rocke; Jenny K Hoang; Jane L Weissman; David M Kaylie
Journal:  Neuroradiology       Date:  2017-06-16       Impact factor: 2.804

6.  Accelerated Internal Auditory Canal Screening Magnetic Resonance Imaging Protocol With Compressed Sensing 3-Dimensional T2-Weighted Sequence.

Authors:  Mikell Yuhasz; Michael J Hoch; Mari Hagiwara; Mary T Bruno; James S Babb; Esther Raithel; Christoph Forman; Abbas Anwar; J Thomas Roland; Timothy M Shepherd
Journal:  Invest Radiol       Date:  2018-12       Impact factor: 6.016

7.  Intralabyrinthine schwannomas: imaging diagnosis and classification.

Authors:  K L Salzman; A M Childs; H C Davidson; R J Kennedy; C Shelton; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-08       Impact factor: 3.825

Review 8.  Imaging diagnosis and fundamental knowledge of common brain tumors in adults.

Authors:  Akio Tanaka
Journal:  Radiat Med       Date:  2006-07

9.  Flow ghost artifact in slice-encoding direction mimicking vestibular schwannoma in contrast-enhanced 3D spoiled gradient-echo sequence.

Authors:  Shinji Naganawa; Tokiko Koshikawa; Hiroshi Fukatsu; Takeo Ishigaki; Ikuo Aoki
Journal:  Eur Radiol       Date:  2003-11-05       Impact factor: 5.315

10.  Diagnostic accuracy of the constructive interference in steady state sequence alone for follow-up imaging of vestibular schwannomas.

Authors:  B Ozgen; B Oguz; A Dolgun
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.